Dyno Therapeutics

About:

Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.

Twitter/X: dyno_tx

Top Investors: Andreessen Horowitz, Google Ventures, Polaris Partners, Lux Capital, CRV

Description:

Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.

Total Funding Amount:

$109M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)dynotx.com

Founders:

Adrian Veres, Alan Crane, Eric Kelsic, George Church, Sam Sinai, Tomas Bjorklund

Number of Employees:

101-250

Last Funding Date:

2021-05-06

IPO Status:

Private

Industries:

Health Care

Biotechnology

Artificial Intelligence (AI)